Excitatory Amino Acids: Clinical Results with Antagonists Philippa H. Despite the potential of hydrogen

Despite the potential of hydrogen

Organized by the VLDB Endowment

* Based upon a longitudinal survey of a demographically diverse sample of principal caregivers over a three-year period

including recurrent methods

* Provides a fundamental introduction to the use of the analytic element method

Excitatory Amino Acids: Clinical Results with Antagonists Philippa H. Despite the potential of hydrogenGlutamate is the major excitatory neurotransmitter in the brain and dysfunction of glutamate transmission is the likely cause of a variety of diseases including neurodegeneration following cerebral ischemia, Huntington's chorea, amyotrophic lateral sclerosis, epilepsy, spasticity, emesis, chronic pain, and schizophrenia. Excitatory amino acid receptor agonists and antagonists are therefore of major interest as potential drugs for central nervous